Home » Topics » BioWorld Science

BioWorld Science
RSS

NBTXR3 improves survival in preclinical model of anti-PD-1-resistant lung cancer

Jan. 28, 2022

PDS-0202 universal flu vaccine neutralizes multiple strains of influenza in preclinical studies

Jan. 28, 2022

Cereno advances CS-014 for cardiovascular diseases

Jan. 28, 2022

Chinese researchers discover new SST2 receptor ligands

Jan. 28, 2022

Bacainn Therapeutics synthesizes new NLRP inflammasome inhibitors

Jan. 28, 2022

Gilgamesh Pharmaceuticals identifies new 5-HT2A receptor agonists

Jan. 28, 2022

BridGene Biosciences divulges YAP1/TEAD interaction inhibitors

Jan. 28, 2022

Pfizer patents new JAK inhibitors

Jan. 28, 2022

Beta-elemene NO derivatives demonstrate potent antiglioma activity in vivo

Jan. 28, 2022

Novel nonviral engineered BAFF-CAR T cells show efficacy in multiple B-cell cancer models

Jan. 28, 2022

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...